FLT3 and leukemia: Our study confirms that FLT3-ITD mutations apparently increase the levels of p-STAT5 and subsequently upregulate the expression of the target gene Pim-1, leading to an increase in the expression of CXCR4 on the surface of leukemia cells that in turn contributes to chemotherapy resistance and disease relapse.